Aignostics develops an AI platform for digital pathology to improve cancer diagnostics and therapy decisions. The CE-certified solution analyzes tissue images through deep learning, supports pathologists in precise tumor classification, enables biomarker discovery for personalized medicine, and accelerates clinical trials through automated histopathological evaluation.
